Literature DB >> 9163630

Successful treatment of juvenile rheumatoid arthritis associated haemophagocytic syndrome by cyclosporin A with transient exacerbation by conventional-dose G-CSF.

B Quesnel, B Catteau, V Aznar, F Bauters, P Fenaux.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163630

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Weathering the storm: Improving therapeutic interventions for cytokine storm syndromes by targeting disease pathogenesis.

Authors:  Lehn K Weaver; Edward M Behrens
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-02-07

Review 2.  Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Annu Rev Med       Date:  2014-11-05       Impact factor: 13.739

3.  Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.

Authors:  Jin-Seok Lee; Jin-Han Kang; Geon-Kook Lee; Hyeon-Jin Park
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

Review 4.  Macrophage activation syndrome and cytokine-directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-04       Impact factor: 4.098

Review 5.  Macrophage activation syndrome: early diagnosis is key.

Authors:  Butsabong Lerkvaleekul; Soamarat Vilaiyuk
Journal:  Open Access Rheumatol       Date:  2018-08-31

Review 6.  Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities.

Authors:  Puja Mehta; Joanna C Porter; Jessica J Manson; John D Isaacs; Peter J M Openshaw; Iain B McInnes; Charlotte Summers; Rachel C Chambers
Journal:  Lancet Respir Med       Date:  2020-06-16       Impact factor: 30.700

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.